Skip to main content
GRND
NYSE Technology

Grindr Q2 Revenue Jumps 33% to $138M, Beating Estimates, but Cash Dwindles to $6.5M After Aggressive Buybacks

Arie Shkolnikov · Analysis by Wiseek AI
More coverage: Software Stocks · Technology
Sentiment info
Neutral
Importance info
8
Price
$16.91
Mkt Cap
$2.947B
52W Low
$9.732
52W High
$18.691
52W Position info
74% above low
Off High info
9.5% below high
Rel. Volume info
1.6× avg
Market data snapshot near publication time

GRND sits 74% above its 52-week low of $9.732.

Summary

Grindr's Q2 revenue beat estimates with 33% growth, but cash fell to $6.5M after heavy buyback spending. New insider trading plans and telehealth risk disclosures add governance and operational color.


Key Events · Earnings and Guidance · GRND

  • Q2 Revenue Beat

    Revenue of $138.1M, up 32.5% YoY, exceeding the $132.44M consensus. App-based revenue grew 30.4% to $113.3M, advertising revenue up 43.4% to $24.8M.

  • Cash Plummets to $6.5M

    Cash and equivalents fell from $87.0M at year-end 2025 to $6.5M, driven by $159.9M in payments for equity instruments (ASRs, put options, forward repurchases) under the $900M buyback program.

  • Insider Trading Plans Adopted

    Director G. Raymond Zage III adopted a 10b5-1 plan for up to 6M shares; Director Daniel Brooks Baer for 14K shares; Chief Product Officer Austin Balance for 89,638 shares.

  • Telehealth Risk Factors Added

    New risk disclosures detail regulatory exposure from Woodwork telehealth service, including compounded GLP-1 drugs and dietary supplements, citing FDA warning letters and potential litigation.


Analysis · GRND · Technology

Grindr delivered a strong Q2, with revenue up 33% year-over-year to $138.1 million, beating the $132.4 million consensus. Adjusted EBITDA rose 27% to $57.6 million. However, the company's cash position collapsed to just $6.5 million from $87 million at year-end, largely due to $159.9 million spent on equity instruments for share buybacks. While the buybacks signal confidence, the depleted cash raises liquidity concerns given $386 million in debt. The filing also reveals new 10b5-1 trading plans from the largest shareholder and other insiders, and updated risk factors around its new telehealth service.

How filings like this one have moved

In the 30 days to Oct 13, 2026, 36.5% of the 995 measured filings Wiseek scored 8 moved their stock by 5% or more by the next session's close. The median move was -0.63%. These are measured outcomes after filings of this importance, not a forecast for this one.

Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset

At the time of this filing, GRND was trading at $16.91 on NYSE in the Technology sector, with a market capitalization of approximately $2.9B. The 52-week trading range was $9.73 to $18.69. This filing was assessed with neutral market sentiment and an importance score of 8 out of 10.

View Main SEC Filing

Price Chart

Share this article

Copied!

GRND - Latest Insights

GRND
Oct 02, 2026, 4:26 PM EDT
Filing Type: 144
Importance Score:
7
Price at Filing: $13.62
Real-time Price: $15.47 info
Change: +$1.85 (+14%) info
Market Cap: $2.689B info
GRND
Sep 30, 2026, 5:02 PM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $15.40
Real-time Price: $15.47 info
Change: +$0.070 (+0.45%) info
Market Cap: $2.689B info
GRND
Sep 30, 2026, 4:45 PM EDT
Source: Dow Jones Newswires
Importance Score:
8
Price at Filing: $15.40
Real-time Price: $15.47 info
Change: +$0.070 (+0.45%) info
Market Cap: $2.689B info
GRND
Sep 04, 2026, 5:16 PM EDT
Source: Reuters
Importance Score:
7
Price at Filing: $15.25
Real-time Price: $15.47 info
Change: +$0.220 (+1%) info
Market Cap: $2.689B info
GRND
Sep 04, 2026, 5:09 PM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $15.25
Real-time Price: $15.47 info
Change: +$0.220 (+1%) info
Market Cap: $2.689B info